Drug store chain operator CVS Health Corp (NYSE:CVS) early today posted mixed Q3 earnings and offered a very weak outlook, as big pharmacy network changes will lead to the loss of over 40 million prescriptions.
The Woonsocket, RI-based company reported Q3 EPS of $1.64, beating out Wall Street’s $1.57 estimate by 7 cents. Revenue rose 15.5% from last year to $44.62 billion, however, missing analysts’ $45.29 billion view.